Hostname: page-component-cd9895bd7-7cvxr Total loading time: 0 Render date: 2024-12-31T20:28:34.842Z Has data issue: false hasContentIssue false
  • English
  • Français

Acetarsol in the Treatment of Late Congenital Syphilis amongst Mental Defectives

Published online by Cambridge University Press:  19 February 2018

K. C. L. Paddle
K. C. L. Paddle*
Affiliation:
Botleys Park, Chertsey; late Deputy Medical Superintendent, Caterham Hospital (L.C.C.)
Get access Rights & Permissions [Opens in a new window]

Extract

The treatment of congenital syphilis, in spite of the advances in the general treatment of syphilis in the last thirty years, still leaves much to be desired. Veeder, after treating some 500 cases of congenital syphilis in St. Louis between 1912 and 1920, came to the conclusion that the results of treatment were most unsatisfactory, and that very little was to be gained by the treatment of the syphilitic child. He advocated the treatment of the parents to prevent the birth of syphilitic children. Nabarro is of opinion that the criterion of cure should be the complete cessation of any symptoms of activity and a normal blood and cerebro-spinal fluid. He has not been able to fix any limit of time after which he can regard the patient as cured. He mentions a case of his which relapsed with interstitial keratitis after having had a negative Wasser mann reaction for eight years. Ambrose King doubts whether congenital syphilis is ever really cured; he states that “cases had been seen in which manifestations of congenital syphilis appeared only after the lapse of a number of years, and others in which active lesions occurred, but with a negative Wassermann”.

Type
Part I.—Original Articles
Information
Journal of Mental Science , Volume 83 , Issue 345 , July 1937 , pp. 372 - 407
Copyright
Copyright © Royal College of Psychiatrists, 1937 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Abt, A. F., and Traisman, A. S., “Stovarsol in the Peroral Treatment of Congenital Syphilis”, Journ. Pediat., 1932, i, p. 172.Google Scholar
Bender, W. L., “Stovarsol Poisoning”, Amer. Journ. Med. Sci., 1927, clxxiv, p. 819.Google Scholar
Bratusch-Marrain, , Alois, , “Wert und Durch-führung der Spirocidbehandlung der Syphilis im Kindesalter”, Arch. f. Kinderheilkunde, 1930, xcii, i, pp. 26–39.Google Scholar
Davidson, A. M., and Birt, A. R., “The Treatment of Congenital Syphilis with Stovarsol”, Canadian Med. Assoc. Journ., 1936, xxxiv, p. 33.Google Scholar
Ehrlich, P., and Hata, S., Die Experimentelle Chemotherapie der Spirillosen, 1911, Berlin.Google Scholar
Findlay, G. M., Recent Advances in Chemotherapy, 1930, London, p. 344.Google Scholar
Fourneau, E., “Sur l'emploi de l'acide oxyaminophenyl-arsinique et des acides arylarsiniques en général dans le traitement des spirilloses et des trypanosomiases”, Ann. de l'Inst. Pasteur, 1921, xxxv, p. 571.Google Scholar
Hutchinson, J. Sir, Syphilis, second edition, p. 511.Google Scholar
Izar, G., Paris Méd., 1925, p. 139.Google Scholar
King, Ambrose, “Discussion on the Treatment of Congenital Syphilis”, Brit. Journ. of Ven. Dis., 1934, x, p. 25.Google Scholar
Levaditi, C., and Nabarro-Martin, A., “Recherches sur l'action curative et préventive de l'acide acetyloxyamino-phenylarsinique (190 ou Stovarsol) administré par voie digestive dans la syphilis”, Ann. de l'Inst. Pasteur, 1922, xxxv, p. 729.Google Scholar
MacQueen, J., “Syphilis Insontium in Palestine”, Brit. Journ. of Ven. Dis., 1934, x, p. 47.Google Scholar
Mann, S. A, and Partner, F., Memorandum on the Wassermann Reaction in Mental Hospitals' Practice, 1931 (King & Son, Ltd.).Google Scholar
Maxwell, C. H., and Glaser, J. “Treatment of Congenital Syphilis with Acetarsone given by Mouth”, Amer. Journ. Dis. Child., 1932, xliii, p. 1461.Google Scholar
Michael, J. C., “Exfoliative Dermatitis from Acetarsone”, Journ. Amer. Med. Assoc., 1929, xcii, p. 645.Google Scholar
Nabarro, D., “Discussion on the Treatment of Congenital Syphilis”, Brit. Journ. of Ven. Dis. 1934, x, pp. 8 and 7; Proc. Roy. Soc. Med., 1934, xxviii, p. 170.Google Scholar
O'Brien, J. R., Lancet, 1926, i, p. 313 Google Scholar
Paddle, K. C. L., “Congenital Syphilis in Low-Grade Mentally Defective Children”, Brit. Journ. of Child. Dis., 1933, xxx, pp. 249–261; “Hydrocephalus and Endocarditis in a Congenital Syphilitic Mental Defective”, Brit. Journ. of Ven. Dis., 1933, ix, p. 145.Google Scholar
Semon, Henry C., “Acute Stovarsol Dermatitis”, Lancet, 1932, ii, p. 340.Google Scholar
Sézary, A., and Barbé, A., “Résultats cliniques et biologiques de la stovarsol-thérapie dans 125 cas de paralysie générale”, Paris Méd., 1929, xxxvii, p. 1.Google Scholar
Veeder, Borden S., “Hereditary Syphilis in the Light of Recent Clinical Studies”, Amer. Journ. of Med. Sci., 1916, clii, p. 522.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.